JP2005533811A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533811A5
JP2005533811A5 JP2004516055A JP2004516055A JP2005533811A5 JP 2005533811 A5 JP2005533811 A5 JP 2005533811A5 JP 2004516055 A JP2004516055 A JP 2004516055A JP 2004516055 A JP2004516055 A JP 2004516055A JP 2005533811 A5 JP2005533811 A5 JP 2005533811A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
aryl
heteroaryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004516055A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533811A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/019585 external-priority patent/WO2004000821A1/en
Publication of JP2005533811A publication Critical patent/JP2005533811A/ja
Publication of JP2005533811A5 publication Critical patent/JP2005533811A5/ja
Pending legal-status Critical Current

Links

JP2004516055A 2002-06-20 2003-06-20 5−(1,3−オキサゾル−2−イル)安息香酸誘導体の調製方法 Pending JP2005533811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (2)

Publication Number Publication Date
JP2005533811A JP2005533811A (ja) 2005-11-10
JP2005533811A5 true JP2005533811A5 (enExample) 2006-07-20

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004516055A Pending JP2005533811A (ja) 2002-06-20 2003-06-20 5−(1,3−オキサゾル−2−イル)安息香酸誘導体の調製方法

Country Status (17)

Country Link
US (2) US7115747B2 (enExample)
EP (1) EP1532123B1 (enExample)
JP (1) JP2005533811A (enExample)
CN (1) CN1324017C (enExample)
AT (1) ATE370131T1 (enExample)
AU (1) AU2003249344A1 (enExample)
BR (1) BR0312439A (enExample)
CA (1) CA2489988A1 (enExample)
CO (1) CO5670350A2 (enExample)
DE (1) DE60315664D1 (enExample)
EA (1) EA008389B1 (enExample)
IL (1) IL165763A0 (enExample)
MX (1) MXPA04012630A (enExample)
NO (1) NO20045497L (enExample)
NZ (1) NZ537390A (enExample)
PL (1) PL374999A1 (enExample)
WO (1) WO2004000821A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05005649A (es) * 2002-11-27 2005-08-16 Elan Pharm Inc Ureas y carbamatos sustituidos.
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
WO2007061670A1 (en) 2005-11-21 2007-05-31 Amgen Inc. Beta-secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
WO2008137954A2 (en) * 2007-05-07 2008-11-13 Environmental Packaging Technologies Limited Universal shipping container
AU2008257145B2 (en) 2007-05-25 2011-11-10 Amgen Inc. Substituted hydroxyethyl amine compounds as Beta-secretase modulators and methods of use
CL2008001500A1 (es) 2007-05-25 2008-12-26 Amgen Inc Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros.
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
CN102209721A (zh) 2008-09-11 2011-10-05 安姆根有限公司 作为β-分泌酶调节剂的螺四环化合物及其使用方法
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
US8822485B2 (en) 2009-11-23 2014-09-02 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011090911A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
US8883782B2 (en) 2010-03-15 2014-11-11 Amgen Inc. Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
EP2547686B1 (en) 2010-03-15 2014-01-22 Amgen Inc. Amino-dihydrooxazine and amino-dihydrothiazine spiro compounds as beta-secretase modulators and their medical use
EP2673279A1 (en) 2011-02-07 2013-12-18 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use
JP2014526560A (ja) 2011-09-21 2014-10-06 アムジエン・インコーポレーテツド β‐セクレターゼ調節因子としてのアミノオキサジン化合物およびアミノジヒドロチアジン化合物および使用方法
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020276A1 (es) * 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
WO2003029169A2 (en) * 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
IL161881A0 (en) * 2001-11-08 2005-11-20 Upjohn Co N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2005533811A5 (enExample)
JP2005534614A5 (enExample)
RU2000127105A (ru) Соединения с активностью в отношении мускариновых рецепторов
RU2010133903A (ru) Способ и промежуточные соединения для получения производных 5-бифенил-4-ил-2-метилпентановой кислоты
RU2002119019A (ru) Замещенные амидазолы-антагонисты рецептора Y5 нейропептида Y
JP2008513432A5 (enExample)
JP2004532894A5 (enExample)
RU2007125710A (ru) Способ получения n-фенилпиразол-1-карбоксамидов
JPWO2019126691A5 (enExample)
JP2008510691A5 (enExample)
JPS58185553A (ja) α−保護されたオキシイミノ−β−ケト−γ−ハロゲノ酪酸類
PE20021091A1 (es) Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion
AR044688A1 (es) Agentes terapeuticos utiles para el tratamiento del dolor
AR084280A1 (es) Compuestos heterociclicos nitrogenados sustituidos fusionados en posicion 6,6 y usos de los mismos
RU2009109160A (ru) Инсектицидные изоксазолины
RU96105988A (ru) Замещенные арилоксиалкилдиамины, обладающие сосудосуживающим действием
JP2011503096A5 (enExample)
JP2006508147A5 (enExample)
RU2004101053A (ru) Способ и промежуточные соединения для получения латанопроста
JP2020535124A5 (enExample)
JPWO2019241292A5 (enExample)
JPWO2022251502A5 (enExample)
RU2006145444A (ru) Способ получения производных 1,4-дифенилазетидинона
JP2007538042A5 (enExample)
JP2012233169A5 (enExample)